Ropes & Gray advised Ovid Therapeutics on the deal. Ovid Therapeutics announced a collaboration with Graviton Bioscience Corporation under which Ovid obtained exclusive rights to develop...
Ovid Therapeutics’ Collaboration with Graviton Bioscience
Pfizer’s Collaboration With Biohaven Pharmaceutical Company
Ropes & Gray represented Pfizer in the deal. Pfizer announced its collaboration arrangement with Biohaven Pharmaceutical Company to commercialize rimegepant, a therapy approved in the U.S. as...
Sunovion Pharmaceuticals’ Co-Development and Co-Commercialization Agreement with Otsuka Pharmaceutical
Ropes & Gray advised Sunovion Pharmaceuticals on the deal while Cooley represented Otsuka Pharmaceutical. Sunovion Pharmaceuticals Inc., a subsidiary of Japan’s Sumitomo Dainippon Pharma, signed a...
iTeos Therapeutics’ Cancer Drug Collaboration with GSK
Ropes & Gray advised iTeos Therapeutics in the deal. iTeos Therapeutics closed a collaboration with global healthcare leader GSK to co-develop and co-commercialize an anti-TIGIT monoclonal...